Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sidoris Biomedical is a medical device company focused on the commercialization of surgical products utilizing proprietary bioresorbable metal technology. Formed as a subsidiary of Advancing Medical Innovation (AMI), the company leverages technology licensed from BioDG, Inc. to develop implants that provide structural support during the healing process and then safely dissolve. Its initial focus includes internal and external surgical stapling, surgical mesh, and fixation devices, with successful pre-clinical results demonstrated in gastrointestinal anastomosis. The company aims to partner with industry leaders to bring these next-generation bioresorbable solutions to the clinical market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sidoris Biomedical.